Factors Influencing the Hormone Receptor and HER2 Levels in Breast Cancer: A Population-Based Analysis

Publisher： Karger

E-ISSN： 2296-5262|35|3|95-98

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.3, 2012-02, pp. : 95-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stage IV breast cancer: a population‐based study about prognostic factors according to HER2 and HR status

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 6, 2015-11 ,pp. : 920-928

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2++ metastatic breast cancer with letrozole alone or in combination with lapatinib

By Sherrill Beth   Sherif Bintu   Amonkar Mayur M.   Maltzman Julie   O’Rourke Lisa   Johnston Stephen  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2245-2252

Informa Healthcare

Access to resources Recommend Favorite

Location of Residence and Breast Cancer Stage: A SEER Population‐based Analysis

By  

THE BREAST JOURNAL, Vol. 21, Iss. 6, 2015-11 ,pp. : 693-695

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population-Based Patient Care Study for Breast Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-05 ,pp. : 168-173

Karger

Access to resources Recommend Favorite

Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative

By  

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 2, 2018-01 ,pp. : e158-e168

John Wiley & Sons Inc

Access to resources Recommend Favorite